{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T01:42:02Z","timestamp":1792114922077,"version":"4.4.0"},"reference-count":102,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,2,9]],"date-time":"2022-02-09T00:00:00Z","timestamp":1644364800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,2,9]],"date-time":"2022-02-09T00:00:00Z","timestamp":1644364800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["165381\/2015-9"],"award-info":[{"award-number":["165381\/2015-9"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["312656\/2019-0"],"award-info":[{"award-number":["312656\/2019-0"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Cryptococcal meningitis causes high mortality in immunocompromised and immunocompetent patients. The objective of this study was to identify early predictors of clinical outcome, available at the first days of hospitalization, in patients with cryptococcal meningitis in a tertiary center in Brazil.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Ninety-six cases of cryptococcal meningitis with clinical, epidemiological and laboratory data, and identification and antifungal susceptibility of the strains were analyzed. Quantitative CSF yeast counts were performed by direct microscopic exam with a Fuchs-Rosenthal cell counting chamber using an institutional protocol. Univariable and multiple analyses using logistic regression were performed to identify predictors, available at the beginning of hospitalization, of in-hospital mortality. Moreover, we performed a secondary analysis for a composite outcome defined by hospital mortality and intensive care unit transfer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The species and the antifungal susceptibility were not associated with the outcomes evaluated. The variables significantly associated with the mortality were age (OR\u2009=\u20091.08, 95% CI 1.02\u20131.15), the cerebrospinal fluid (CSF) yeasts count (OR\u2009=\u20091.65, 95% CI 1.20\u20132.27), systemic arterial hypertension (OR\u2009=\u200922.63, 95% CI 1.64\u2013312.91) and neurological impairment identified by computed tomography (OR\u2009=\u200941.73, 95% CI 3.10\u2013561.65). At the secondary analysis, CSF yeast count was also associated with the composite outcome, in addition to the culture of\n                      <jats:italic>Cryptococcus<\/jats:italic>\n                      spp. from bloodstream and cerebral toxoplasmosis. The associations were consistent with survival models evaluated.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      Age and CSF yeast count were independently associated with in-hospital mortality of patients with cryptococcal meningitis but\n                      <jats:italic>Cryptococcus<\/jats:italic>\n                      species identification and antifungal susceptibility were not associated with the outcomes. Quantitative CSF yeast counts used in this study can be evaluated and implemented in other low and middle-income settings.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-022-07118-7","type":"journal-article","created":{"date-parts":[[2022,2,9]],"date-time":"2022-02-09T10:02:43Z","timestamp":1644400963000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Early clinical and microbiological predictors of outcome in hospitalized patients with cryptococcal meningitis"],"prefix":"10.1186","volume":"22","author":[{"given":"Lidiane","family":"de Oliveira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcia de Souza Carvalho","family":"Melhem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata","family":"Buccheri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar Jos\u00e9","family":"Chagas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Ernesto","family":"Vidal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fredi Alexander","family":"Diaz-Quijano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,9]]},"reference":[{"issue":"1","key":"7118_CR1","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1146\/annurev.micro.60.080805.142102","volume":"60","author":"X Lin","year":"2006","unstructured":"Lin X, Heitman J. The biology of the Cryptococcus neoformans species complex. Annu Rev Microbiol. 2006;60(1):69\u2013105. https:\/\/doi.org\/10.1146\/annurev.micro.60.080805.142102.","journal-title":"Annu Rev Microbiol"},{"issue":"1","key":"7118_CR2","doi-asserted-by":"publisher","first-page":"718","DOI":"10.2741\/1830","volume":"11","author":"LD Valle","year":"2006","unstructured":"Valle LD. HIV disorders of the brain; pathology and pathogenesis. Front Biosci. 2006;11(1):718. https:\/\/doi.org\/10.2741\/1830.","journal-title":"Front Biosci"},{"issue":"2","key":"7118_CR3","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.diagmicrobio.2009.02.007","volume":"64","author":"MCSM Pappalardo","year":"2009","unstructured":"Pappalardo MCSM, Szeszs MW, Martins MA, et al. Susceptibility of clinical isolates of Cryptococcus neoformans to amphotericin B using time\u2013kill methodology. Diagn Microbiol Infect Dis. 2009;64(2):146\u201351. https:\/\/doi.org\/10.1016\/j.diagmicrobio.2009.02.007.","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"5\u20136","key":"7118_CR4","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s11046-011-9504-9","volume":"173","author":"DJ Mora","year":"2012","unstructured":"Mora DJ, da Cunha Colombo ER, Ferreira-Paim K, Andrade-Silva LE, Nascentes GAN, Silva-Vergara ML. Clinical, epidemiological and outcome features of patients with Cryptococcosis in Uberaba, Minas Gerais, Brazil. Mycopathologia. 2012;173(5\u20136):321\u20137. https:\/\/doi.org\/10.1007\/s11046-011-9504-9.","journal-title":"Mycopathologia"},{"key":"7118_CR5","doi-asserted-by":"publisher","unstructured":"Domingues CSB, Waldman EA. Causes of death among people living with aids in the pre- and post-HAART eras in the city of S\u00e3o Paulo, Brazil. In: Vermund SH, editor. PLoS ONE. 2014;9(12):e114661. https:\/\/doi.org\/10.1371\/journal.pone.0114661","DOI":"10.1371\/journal.pone.0114661"},{"issue":"10","key":"7118_CR6","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1093\/trstmh\/trx083","volume":"111","author":"JA Opintan","year":"2017","unstructured":"Opintan JA, Awadzi BK, Biney IJK, et al. High rates of cerebral toxoplasmosis in HIV patients presenting with meningitis in Accra, Ghana. Trans R Soc Trop Med Hyg. 2017;111(10):464\u201371. https:\/\/doi.org\/10.1093\/trstmh\/trx083.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"7118_CR7","unstructured":"World Health Organization. Guidelines on the Diagnosis, prevention and management of cryptococcal disease in HIV-infected adults, adolescents and children: Supplement to the 2016 consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection; 2018."},{"key":"7118_CR8","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.fgb.2015.02.009","volume":"78","author":"F Hagen","year":"2015","unstructured":"Hagen F, Khayhan K, Theelen B, et al. Recognition of seven species in the Cryptococcus gattii\/Cryptococcus neoformans species complex. Fungal Genet Biol. 2015;78:16\u201348. https:\/\/doi.org\/10.1016\/j.fgb.2015.02.009.","journal-title":"Fungal Genet Biol"},{"issue":"11","key":"7118_CR9","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/j.micinf.2011.05.009","volume":"13","author":"EJ Byrnes","year":"2011","unstructured":"Byrnes EJ, Bartlett KH, Perfect JR, Heitman J. Cryptococcus gattii: an emerging fungal pathogen infecting humans and animals. Microbes Infect. 2011;13(11):895\u2013907. https:\/\/doi.org\/10.1016\/j.micinf.2011.05.009.","journal-title":"Microbes Infect"},{"key":"7118_CR10","doi-asserted-by":"publisher","first-page":"328","DOI":"10.3109\/13693786.2011.602126","volume":"50","author":"L Trilles","year":"2012","unstructured":"Trilles L, Meyer W, Wanke B, Guarro J, Laz\u00e9ra M. Correlation of antifungal susceptibility and molecular type within the Cryptococcus neoformans\/C. gattii species complex. Med Mycol. 2012;50:328.","journal-title":"Med Mycol"},{"key":"7118_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2013\/675213","volume":"2013","author":"M Cogliati","year":"2013","unstructured":"Cogliati M. Global molecular epidemiology of Cryptococcus neoformans and Cryptococcus gattii: an atlas of the molecular types. Scientifica. 2013;2013:1\u201323. https:\/\/doi.org\/10.1155\/2013\/675213.","journal-title":"Scientifica"},{"key":"7118_CR12","doi-asserted-by":"publisher","unstructured":"Beale MA, Sabiiti W, Robertson EJ, et al. Genotypic diversity is associated with clinical outcome and phenotype in cryptococcal meningitis across southern Africa. In: Vinetz JM, ed. PLOS Negl Trop Dis. 2015;9(6):e0003847. https:\/\/doi.org\/10.1371\/journal.pntd.0003847","DOI":"10.1371\/journal.pntd.0003847"},{"key":"7118_CR13","doi-asserted-by":"publisher","DOI":"10.1093\/mmy\/myy150","author":"MM Nishikawa","year":"2019","unstructured":"Nishikawa MM, Almeida-Paes R, Brito-Santos F, et al. Comparative antifungal susceptibility analyses of Cryptococcus neoformans VNI and Cryptococcus gattii VGII from the Brazilian Amazon Region by the Etest, Vitek 2, and the Clinical and Laboratory Standards Institute broth microdilution methods. Med Mycol. 2019. https:\/\/doi.org\/10.1093\/mmy\/myy150.","journal-title":"Medical Mycology"},{"issue":"4","key":"7118_CR14","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.mycmed.2018.09.005","volume":"28","author":"K Pakshir","year":"2018","unstructured":"Pakshir K, Fakhim H, Vaezi A, et al. Molecular epidemiology of environmental Cryptococcus species isolates based on amplified fragment length polymorphism. J de Mycologie M\u00e9dicale. 2018;28(4):599\u2013605. https:\/\/doi.org\/10.1016\/j.mycmed.2018.09.005.","journal-title":"J de Mycologie M\u00e9dicale"},{"key":"7118_CR15","doi-asserted-by":"publisher","DOI":"10.1590\/0074-02760170554","author":"C Firacative","year":"2018","unstructured":"Firacative C, Lizarazo J, Illnait-Zaragoz\u00ed MT, Casta\u00f1eda E. The status of cryptococcosis in Latin America. Mem\u00f3rias do Instituto Oswaldo Cruz. 2018. https:\/\/doi.org\/10.1590\/0074-02760170554.","journal-title":"Mem\u00f3rias do Instituto Oswaldo Cruz."},{"key":"7118_CR16","doi-asserted-by":"publisher","unstructured":"Hagen F, Lumbsch HT, Arsic Arsenijevic V, et al. Importance of resolving fungal nomenclature: the case of multiple pathogenic species in the Cryptococcus genus. In: Lorenz M, editor. mSphere. 2017;2(4). https:\/\/doi.org\/10.1128\/mSphere.00238-17","DOI":"10.1128\/mSphere.00238-17"},{"issue":"7","key":"7118_CR17","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1128\/jcm.28.7.1642-1644.1990","volume":"28","author":"DH Ellis","year":"1990","unstructured":"Ellis DH, Pfeiffer TJ. Natural habitat of Cryptococcus neoformans var. gattii. J Clin Microbiol. 1990;28(7):1642\u20134.","journal-title":"J Clin Microbiol."},{"key":"7118_CR18","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1080\/mmy.38.5.385.390","volume":"38","author":"H Montenegro","year":"2000","unstructured":"Montenegro H, Paula CR. Environmental isolation of Cryptococcus neoformans var. gattii and C. neoformans var. neoformans in the city of S\u00e3o Paulo, Brazil. Med Mycol. 2000;38:385.","journal-title":"Med Mycol"},{"key":"7118_CR19","first-page":"9","volume":"28","author":"P Ngamskulrungroj","year":"2009","unstructured":"Ngamskulrungroj P, Meyer W. Melanin production at 37\u00b0C is linked to the high virulent Cryptococcus gattii Vancouver Island outbreak genotype VGIIa. Australasian Mycologist. 2009;28:9\u201314.","journal-title":"Australasian Mycologist"},{"issue":"8","key":"7118_CR20","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/S1473-3099(17)30243-8","volume":"17","author":"R Rajasingham","year":"2017","unstructured":"Rajasingham R, Smith RM, Park BJ, et al. Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis. Lancet Infect Dis. 2017;17(8):873\u201381. https:\/\/doi.org\/10.1016\/S1473-3099(17)30243-8.","journal-title":"Lancet Infect Dis"},{"issue":"9","key":"7118_CR21","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1086\/339540","volume":"34","author":"EL Corbett","year":"2002","unstructured":"Corbett EL, Churchyard GJ, Charalambos S, et al. Morbidity and mortality in South African gold miners: impact of untreated disease due to human immunodeficiency virus. Clin Infect Dis. 2002;34(9):1251\u20138. https:\/\/doi.org\/10.1086\/339540.","journal-title":"Clin Infect Dis"},{"issue":"5","key":"7118_CR22","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1093\/cid\/cit794","volume":"58","author":"JN Jarvis","year":"2014","unstructured":"Jarvis JN, Bicanic T, Loyse A, et al. Determinants of Mortality in a combined cohort of 501 patients with hiv-associated cryptococcal meningitis: implications for improving outcomes. Clin Infect Dis. 2014;58(5):736\u201345. https:\/\/doi.org\/10.1093\/cid\/cit794.","journal-title":"Clin Infect Dis"},{"issue":"4","key":"7118_CR23","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1097\/QAD.0b013e328322ffac","volume":"23","author":"BJ Park","year":"2009","unstructured":"Park BJ, Wannemuehler KA, Marston BJ, Govender N, Pappas PG, Chiller TM. Estimation of the current global burden of cryptococcal meningitis among persons living with HIV\/AIDS. AIDS. 2009;23(4):525\u201330. https:\/\/doi.org\/10.1097\/QAD.0b013e328322ffac.","journal-title":"AIDS"},{"key":"7118_CR24","doi-asserted-by":"publisher","unstructured":"Pyrgos V, Seitz Ae, Steiner CA, Prevots DR, Williamson PR. Epidemiology of cryptococcal Meningitis in the US: 1997\u20132009. In: Arez AP, ed. PLoS ONE. 2013;8(2):e56269. https:\/\/doi.org\/10.1371\/journal.pone.0056269.","DOI":"10.1371\/journal.pone.0056269"},{"issue":"3","key":"7118_CR25","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1086\/649858","volume":"50","author":"JR Perfect","year":"2010","unstructured":"Perfect JR, Dismukes WE, Dromer F, et al. Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america. Clin Infect Dis. 2010;50(3):291\u2013322. https:\/\/doi.org\/10.1086\/649858.","journal-title":"Clin Infect Dis"},{"issue":"suppl 2","key":"7118_CR26","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1093\/jac\/dkw394","volume":"71","author":"O Lortholary","year":"2016","unstructured":"Lortholary O, Fern\u00e1ndez-Ruiz M, Perfect JR. The current treatment landscape: other fungal diseases (cryptococcosis, fusariosis and mucormycosis). J Antimicrob Chemother. 2016;71(suppl 2):31\u20136. https:\/\/doi.org\/10.1093\/jac\/dkw394.","journal-title":"J Antimicrob Chemother."},{"issue":"3","key":"7118_CR27","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/S0732-8893(98)00095-9","volume":"32","author":"M Pfaller","year":"1998","unstructured":"Pfaller M, Zhang J, Messer S, et al. Molecular epidemiology and antifungal susceptibility of Cryptococcus neoformans isolates from Ugandan AIDS patients. Diagn Microbiol Infect Dis. 1998;32(3):191\u20139.","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"6","key":"7118_CR28","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1128\/AAC.44.6.1544-1548.2000","volume":"44","author":"AI Aller","year":"2000","unstructured":"Aller AI, Martin-Mazuelos E, Lozano F, et al. Correlation of fluconazole MICs with Clinical outcome in cryptococcal infection. Antimicrob Agents Chemother. 2000;44(6):1544\u20138. https:\/\/doi.org\/10.1128\/AAC.44.6.1544-1548.2000.","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"7118_CR29","doi-asserted-by":"publisher","first-page":"2464","DOI":"10.1128\/AAC.01520-05","volume":"50","author":"E Dannaoui","year":"2006","unstructured":"Dannaoui E, Abdul M, Arpin M, et al. Results Obtained with various antifungal susceptibility testing methods do not predict early clinical outcome in patients with cryptococcosis. Antimicrob Agents Chemother. 2006;50(7):2464\u201370. https:\/\/doi.org\/10.1128\/AAC.01520-05.","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"7118_CR30","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1093\/jac\/45.2.239","volume":"45","author":"L Rodero","year":"2000","unstructured":"Rodero L, C\u00f3rdoba S, Cahn P, et al. In vitro susceptibility studies of Cryptococcus neoformans isolated from patients with no clinical response to amphotericin B therapy. J Antimicrob Chemother. 2000;45(2):239\u201342. https:\/\/doi.org\/10.1093\/jac\/45.2.239.","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"7118_CR31","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.diagmicrobio.2011.11.016","volume":"72","author":"DC Silva","year":"2012","unstructured":"Silva DC, Martins MA, Szeszs MW, Bonfietti LX, Matos D, Melhem MSC. Susceptibility to antifungal agents and genotypes of Brazilian clinical and environmental Cryptococcus gattii strains. Diagn Microbiol Infect Dis. 2012;72(4):332\u20139. https:\/\/doi.org\/10.1016\/j.diagmicrobio.2011.11.016.","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"4","key":"7118_CR32","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1007\/s12281-017-0296-3","volume":"11","author":"L Oliveira","year":"2017","unstructured":"Oliveira L, Santos DCS, dos Martins MA, Szeszs MW, Melhem MSC. Time-Kill Curves studies with amphotericin b against Cryptococcus neoformans\/C. gattii species Complex clinical isolates. Curr Fungal Infect Rep. 2017;11(4):158\u201362. https:\/\/doi.org\/10.1007\/s12281-017-0296-3.","journal-title":"Curr Fungal Infect Rep"},{"issue":"8","key":"7118_CR33","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1128\/AAC.43.8.1856","volume":"43","author":"P Mondon","year":"1999","unstructured":"Mondon P, Petter R, Amalfitano G, et al. Heteroresistance to fluconazole and voriconazole in Cryptococcus neoformans. Antimicrob Agents Chemother. 1999;43(8):1856\u201361. https:\/\/doi.org\/10.1128\/AAC.43.8.1856.","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"7118_CR34","doi-asserted-by":"publisher","first-page":"2804","DOI":"10.1128\/AAC.00295-09","volume":"53","author":"E Sionov","year":"2009","unstructured":"Sionov E, Chang YC, Garraffo HM, Kwon-Chung KJ. Heteroresistance to fluconazole in Cryptococcus neoformans is intrinsic and associated with virulence. Antimicrob Agents Chemother. 2009;53(7):2804\u201315. https:\/\/doi.org\/10.1128\/AAC.00295-09.","journal-title":"Antimicrob Agents Chemother"},{"issue":"8","key":"7118_CR35","doi-asserted-by":"publisher","first-page":"4600","DOI":"10.1128\/AAC.00466-15","volume":"59","author":"GF Ferreira","year":"2015","unstructured":"Ferreira GF, Santos JRA, da Costa MC, et al. Heteroresistance to itraconazole alters the morphology and increases the virulence of Cryptococcus gattii. Antimicrob Agents Chemother. 2015;59(8):4600\u20139. https:\/\/doi.org\/10.1128\/AAC.00466-15.","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"7118_CR36","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1128\/JCM.41.1.267-272.2003","volume":"41","author":"T Yamazumi","year":"2003","unstructured":"Yamazumi T, Pfaller MA, Messer SA, et al. Characterization of heteroresistance to fluconazole among clinical isolates of Cryptococcus neoformans. J Clin Microbiol. 2003;41(1):267\u201372. https:\/\/doi.org\/10.1128\/JCM.41.1.267-272.2003.","journal-title":"J Clin Microbiol"},{"issue":"3","key":"7118_CR37","doi-asserted-by":"publisher","first-page":"261","DOI":"10.3109\/13693786.2012.715763","volume":"51","author":"JWS Cheong","year":"2013","unstructured":"Cheong JWS, McCormack J. Fluconazole resistance in cryptococcal disease: emerging or intrinsic? Med Mycol. 2013;51(3):261\u20139. https:\/\/doi.org\/10.3109\/13693786.2012.715763.","journal-title":"Med Mycol"},{"issue":"9","key":"7118_CR38","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1111\/myc.12639","volume":"60","author":"GF Ferreira","year":"2017","unstructured":"Ferreira GF, Santos DA. Heteroresistance and fungi. Mycoses. 2017;60(9):562\u20138. https:\/\/doi.org\/10.1111\/myc.12639.","journal-title":"Mycoses"},{"key":"7118_CR39","doi-asserted-by":"publisher","DOI":"10.1590\/0037-8682-0463-2018","volume":"53","author":"LA Schiave","year":"2020","unstructured":"Schiave LA, Nascimento E, Gaspar GG, et al. Minimum concentration of Amphotericin B in serum according to the formulation, dose, and daily or prolonged intermittent therapeutic regimen. Rev Soc Bras Med Trop. 2020;53: e20180463. https:\/\/doi.org\/10.1590\/0037-8682-0463-2018.","journal-title":"Rev Soc Bras Med Trop"},{"issue":"6","key":"7118_CR40","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1128\/am.19.6.955-959.1970","volume":"19","author":"BT Fields","year":"1970","unstructured":"Fields BT, Bates JH, Abernathy RS. Amphotericin B Serum concentrations during therapy. Appl Microbiol. 1970;19(6):955\u20139.","journal-title":"Appl Microbiol"},{"issue":"3","key":"7118_CR41","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1080\/mmy.38.3.201.207","volume":"38","author":"L Rodero","year":"2000","unstructured":"Rodero L, Cordoba S, Cahn P, et al. Timed-kill curves for Cryptococcus neoformans isolated from patients with AIDS. Med Mycol. 2000;38(3):201\u20137.","journal-title":"Med Mycol"},{"issue":"5\u20136","key":"7118_CR42","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s11046-015-9871-8","volume":"179","author":"S C\u00f3rdoba","year":"2015","unstructured":"C\u00f3rdoba S, Vivot W, Szusz W, Isla G, Davel G. Comparison of different in vitro tests to detect Cryptococcus neoformans not susceptible to amphotericin B. Mycopathologia. 2015;179(5\u20136):359\u201371. https:\/\/doi.org\/10.1007\/s11046-015-9871-8.","journal-title":"Mycopathologia"},{"issue":"1","key":"7118_CR43","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.diagmicrobio.2012.01.014","volume":"73","author":"JE Vidal","year":"2012","unstructured":"Vidal JE, Gerhardt J, de Miranda P\u00c9J, et al. Role of quantitative CSF microscopy to predict culture status and outcome in HIV-associated cryptococcal meningitis in a Brazilian cohort. Diagn Microbiol Infect Dis. 2012;73(1):68\u201373. https:\/\/doi.org\/10.1016\/j.diagmicrobio.2012.01.014.","journal-title":"Diagn Microbiol Infect Dis"},{"key":"7118_CR44","unstructured":"Kurtzman C, Fell JW, Boekhout T. The yeasts. 5 edn. Elsevier Science; 2011."},{"issue":"2","key":"7118_CR45","doi-asserted-by":"publisher","first-page":"189","DOI":"10.3201\/eid0902.020246","volume":"9","author":"W Meyer","year":"2003","unstructured":"Meyer W, Casta\u00f1eda A, Jackson S, et al. Molecular typing of IberoAmerican Cryptococcus neoformans isolates. Emerg Infect Dis. 2003;9(2):189.","journal-title":"Emerg Infect Dis"},{"key":"7118_CR46","unstructured":"Arendrup MC, Guinea J, Cuenca-Estrella M, et al. Eucast definitive document e.def 7.3. 21."},{"issue":"5","key":"7118_CR47","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1128\/JCM.43.5.2163-2167.2005","volume":"43","author":"MA Pfaller","year":"2005","unstructured":"Pfaller MA, Messer SA, Boyken L, et al. Global trends in the antifungal susceptibility of Cryptococcus neoformans (1990 to 2004). J Clin Microbiol. 2005;43(5):2163\u20137. https:\/\/doi.org\/10.1128\/JCM.43.5.2163-2167.2005.","journal-title":"J Clin Microbiol"},{"issue":"5","key":"7118_CR48","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1128\/AAC.42.5.1207","volume":"42","author":"ME Klepser","year":"1998","unstructured":"Klepser ME, Ernst EJ, Lewis RE, Ernst ME, Pfaller MA. Influence of test conditions on antifungal time-kill curve results: proposal for standardized methods. Antimicrob Agents Chemother. 1998;42(5):1207\u201312.","journal-title":"Antimicrob Agents Chemother"},{"key":"7118_CR49","doi-asserted-by":"crossref","unstructured":"Hoffmann JP. Regression models for categorical, count, and related variables\u202f: an applied approach. University of California Press; 2016.","DOI":"10.1525\/9780520965492"},{"key":"7118_CR50","doi-asserted-by":"publisher","DOI":"10.5935\/abc.20190204","author":"DB Pr\u00e9coma","year":"2019","unstructured":"Pr\u00e9coma DB, de Oliveira GMM, Sim\u00e3o AF, et al. Updated cardiovascular prevention guideline of the brazilian society of cardiology\u20142019. Arquivos Brasileiros de Cardiologia. 2019. https:\/\/doi.org\/10.5935\/abc.20190204.","journal-title":"Arquivos Brasileiros de Cardiologia."},{"issue":"5","key":"7118_CR51","doi-asserted-by":"publisher","first-page":"e438","DOI":"10.1111\/j.1439-0507.2010.01946.x","volume":"54","author":"R Mdodo","year":"2011","unstructured":"Mdodo R, Moser SA, Jaoko W, et al. Antifungal susceptibilities of Cryptococcus neoformans cerebrospinal fluid isolates from AIDS patients in Kenya. Mycoses. 2011;54(5):e438-442. https:\/\/doi.org\/10.1111\/j.1439-0507.2010.01946.x.","journal-title":"Mycoses"},{"issue":"1","key":"7118_CR52","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1186\/1471-2334-12-361","volume":"12","author":"CH Lee","year":"2012","unstructured":"Lee CH, Chang TY, Liu JW, et al. Correlation of anti-fungal susceptibility with clinical outcomes in patients with cryptococcal meningitis. BMC Infect Dis. 2012;12(1):361.","journal-title":"BMC Infect Dis"},{"issue":"4","key":"7118_CR53","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.riam.2014.07.006","volume":"32","author":"CA Agudelo","year":"2015","unstructured":"Agudelo CA, Mu\u00f1oz C, Ram\u00edrez A, et al. Response to therapy in patients with cryptococcosis and AIDS: association with in vitro susceptibility to fluconazole. Rev Iberoam Micol. 2015;32(4):214\u201320. https:\/\/doi.org\/10.1016\/j.riam.2014.07.006.","journal-title":"Rev Iberoam Micol"},{"key":"7118_CR54","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-015-1023-8","author":"YC Chen","year":"2015","unstructured":"Chen YC, Chang TY, Liu JW, et al. Increasing trend of fluconazole-non-susceptible Cryptococcus neoformans in patients with invasive cryptococcosis: a 12-year longitudinal study. BMC Infect Dis. 2015. https:\/\/doi.org\/10.1186\/s12879-015-1023-8.","journal-title":"BMC Infect Dis"},{"key":"7118_CR55","doi-asserted-by":"publisher","unstructured":"Aguiar de PADF, Pedroso dos RS, Borges AS, Moreira de TA, Ara\u00fajo de LB, R\u00f6der de DVDB. The epidemiology of cryptococcosis and the characterization of Cryptococcus neoformans isolated in a Brazilian University Hospital. Revista do Instituto de Medicina Tropical de S\u00e3o Paulo. 2017. https:\/\/doi.org\/10.1590\/s1678-9946201759013.","DOI":"10.1590\/s1678-9946201759013"},{"issue":"1","key":"7118_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.riam.2017.04.003","volume":"35","author":"A Arechavala","year":"2018","unstructured":"Arechavala A, Negroni R, Messina F, et al. Cryptococcosis in an infectious diseases hospital of Buenos Aires, Argentina. Revision of 2041 cases: diagnosis, clinical features and therapeutics. Revista Iberoamericana de Micolog\u00eda. 2018;35(1):1\u201310. https:\/\/doi.org\/10.1016\/j.riam.2017.04.003.","journal-title":"Revista Iberoamericana de Micolog\u00eda."},{"issue":"5","key":"7118_CR57","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1177\/0956462417732649","volume":"29","author":"AA Shaheen","year":"2018","unstructured":"Shaheen AA, Somayaji R, Myers R, Mody CH. Epidemiology and trends of cryptococcosis in the United States from 2000 to 2007: a population-based study. Int J STD AIDS. 2018;29(5):453\u201360. https:\/\/doi.org\/10.1177\/0956462417732649.","journal-title":"Int J STD AIDS"},{"issue":"3","key":"7118_CR58","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1590\/S0037-86822006000300005","volume":"39","author":"TA de Moreira","year":"2006","unstructured":"de Moreira TA, Ferreira MS, Ribas RM, Borges AS. Criptococose: estudo cl\u00ednico-epidemiol\u00f3gico, laboratorial e das variedades do fungo em 96 pacientes. Revista da Sociedade Brasileira de Medicina Trop. 2006;39(3):255\u20138. https:\/\/doi.org\/10.1590\/S0037-86822006000300005.","journal-title":"Revista da Sociedade Brasileira de Medicina Trop."},{"issue":"2","key":"7118_CR59","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1590\/S0037-86822008000200005","volume":"41","author":"PR da Silva","year":"2008","unstructured":"da Silva PR, de Rabelo RAS, Terra APS, Teixeira DNS. Susceptibility to antifungal agents among Cryptococcus neoformans varieties isolated from patients at a university hospital. Revista da Sociedade Brasileira de Medicina Tropical. 2008;41(2):158\u201362.","journal-title":"Revista da Sociedade Brasileira de Medicina Tropical."},{"key":"7118_CR60","doi-asserted-by":"publisher","first-page":"68","DOI":"10.22278\/2318-2660.2013.v37.n0.a591","volume":"37","author":"AV Mascarenhas-Batista","year":"2013","unstructured":"Mascarenhas-Batista AV, Mascarenhas Souza N, Sacramento E. Fatores progn\u00f3sticos na meningite criptoc\u00f3cica em hospital de refer\u00eancia para doen\u00e7as infecciosas. Revista Baiana de Sa\u00fade P\u00fablica. 2013;37:68. https:\/\/doi.org\/10.22278\/2318-2660.2013.v37.n0.a591.","journal-title":"Revista Baiana de Sa\u00fade P\u00fablica"},{"key":"7118_CR61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/6512468","volume":"2018","author":"AZ de Azambuja","year":"2018","unstructured":"de Azambuja AZ, Wissmann Neto G, Watte G, Antoniolli L, Goldani LZ. cryptococcal meningitis: a retrospective cohort of a Brazilian reference hospital in the post-HAART era of Universal Access. Canadian J Infect Dis Med Microbiol. 2018;2018:1\u20135. https:\/\/doi.org\/10.1155\/2018\/6512468.","journal-title":"Canadian J Infect Dis Med Microbiol"},{"issue":"4","key":"7118_CR62","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1590\/0037-8682-0050-2018","volume":"51","author":"JO de Nunes","year":"2018","unstructured":"de Nunes JO, de Tsujisaki RAS, de Nunes MO, et al. Cryptococcal meningitis epidemiology: 17 years of experience in a state of the Brazilian Pantanal. Revista da Sociedade Brasileira de Medicina Trop. 2018;51(4):485\u201392. https:\/\/doi.org\/10.1590\/0037-8682-0050-2018.","journal-title":"Revista da Sociedade Brasileira de Medicina Trop"},{"issue":"5","key":"7118_CR63","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1590\/S0074-02762008000500002","volume":"103","author":"RV Oliveira","year":"2008","unstructured":"Oliveira RV, Trilles L, dos L\u00e1zera MS, et al. Regional pattern of the molecular types of Cryptococcus neoformans and Cryptococcus gattii in Brazil. Mem Inst Oswaldo Cruz. 2008;103(5):455\u201362.","journal-title":"Mem Inst Oswaldo Cruz."},{"issue":"3","key":"7118_CR64","doi-asserted-by":"publisher","first-page":"e145","DOI":"10.1111\/j.1439-0507.2012.02173.x","volume":"55","author":"AKL Freire","year":"2012","unstructured":"Freire AKL, dos Santos BA, de Lima SI, et al. Molecular characterisation of the causative agents of Cryptococcosis in patients of a tertiary healthcare facility in the state of Amazonas-Brazil: cryptococcosis in the state of Amazonas-Brazil. Mycoses. 2012;55(3):e145\u201350. https:\/\/doi.org\/10.1111\/j.1439-0507.2012.02173.x.","journal-title":"Mycoses"},{"issue":"7","key":"7118_CR65","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1007\/s10096-011-1488-3","volume":"31","author":"CS Matos","year":"2012","unstructured":"Matos CS, Andrade SA, Oliveira NS, Barros TF. Microbiological characteristics of clinical isolates of Cryptococcus spp. in Bahia, Brazil: molecular types and antifungal susceptibilities. Eur J Clin Microbiol Infect Dis. 2012;31(7):1647\u201352. https:\/\/doi.org\/10.1007\/s10096-011-1488-3.","journal-title":"Eur J Clin Microbiol Infect Dis."},{"issue":"6","key":"7118_CR66","doi-asserted-by":"publisher","first-page":"635","DOI":"10.3109\/13693786.2012.761737","volume":"51","author":"L Andrade-Silva","year":"2013","unstructured":"Andrade-Silva L, Ferreira-Paim K, Mora DJ, et al. Susceptibility profile of clinical and environmental isolates of Cryptococcus neoformans and Cryptococcus gattii in Uberaba, Minas Gerais, Brazil. Medical Mycology. 2013;51(6):635\u201340. https:\/\/doi.org\/10.3109\/13693786.2012.761737.","journal-title":"Medical Mycology"},{"key":"7118_CR67","doi-asserted-by":"publisher","DOI":"10.1016\/j.bjid.2018.11.002","author":"F Wirth","year":"2018","unstructured":"Wirth F, Azevedo MI, Goldani LZ. Molecular types of Cryptococcus species isolated from patients with cryptococcal meningitis in a Brazilian tertiary care hospital. Brazilian J Infect Dis. 2018. https:\/\/doi.org\/10.1016\/j.bjid.2018.11.002.","journal-title":"Brazilian J Infect Dis."},{"issue":"4","key":"7118_CR68","doi-asserted-by":"publisher","first-page":"62","DOI":"10.3390\/jof3040062","volume":"3","author":"PF Herkert","year":"2017","unstructured":"Herkert PF, Hagen F, Pinheiro RL, Muro MD, Meis JF, Queiroz-Telles F. Ecoepidemiology of Cryptococcus gattii in developing countries. J Fungi. 2017;3(4):62. https:\/\/doi.org\/10.3390\/jof3040062.","journal-title":"J Fungi"},{"issue":"3","key":"7118_CR69","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/S0732-8893(99)00137-6","volume":"36","author":"YC Chen","year":"2000","unstructured":"Chen YC, Chang SC, Shih CC, et al. Clinical features and in vitro susceptibilities of two varieties of Cryptococcus neoformans in Taiwan. Diagn Microbiol Infect Dis. 2000;36:175.","journal-title":"Diagn Microbiol Infect Dis."},{"issue":"11","key":"7118_CR70","doi-asserted-by":"publisher","first-page":"5733","DOI":"10.1128\/JCM.43.11.5733-5742.2005","volume":"43","author":"N Jain","year":"2005","unstructured":"Jain N, Wickes BL, Keller SM, et al. Molecular epidemiology of clinical cryptococcus neoformans strains from India. J Clin Microbiol. 2005;43(11):5733\u201342. https:\/\/doi.org\/10.1128\/JCM.43.11.5733-5742.2005.","journal-title":"J Clin Microbiol"},{"key":"7118_CR71","doi-asserted-by":"publisher","DOI":"10.3201\/eid1601.090900","author":"E Galanis","year":"2010","unstructured":"Galanis E. Epidemiology of Cryptococcus gattii, British Columbia, Canada, 1999\u20132007. Emerg Infect Dis. 2010. https:\/\/doi.org\/10.3201\/eid1601.090900.","journal-title":"Emerg Infect Dis."},{"key":"7118_CR72","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.clineuro.2018.02.015","volume":"167","author":"P Srivanitchapoom","year":"2018","unstructured":"Srivanitchapoom P, Pitakpatapee Y, Sitthinamsuwan P, Sathornsumetee S. Brainstem dysfunction heralding disseminated cryptococcosis. Clin Neurol Neurosurg. 2018;167:62\u20134. https:\/\/doi.org\/10.1016\/j.clineuro.2018.02.015.","journal-title":"Clin Neurol Neurosurg"},{"issue":"1","key":"7118_CR73","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1186\/s12883-020-01880-4","volume":"20","author":"J Wei","year":"2020","unstructured":"Wei J, Li XY, Zhang Y. Central nervous system Cryptococcoma mimicking demyelinating disease: a case report. BMC Neurol. 2020;20(1):297. https:\/\/doi.org\/10.1186\/s12883-020-01880-4.","journal-title":"BMC Neurol"},{"key":"7118_CR74","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-10-199","author":"TT Chau","year":"2010","unstructured":"Chau TT, Mai NH, Phu NH, et al. A prospective descriptive study of cryptococcal meningitis in HIV uninfected patients in Vietnam\u2014high prevalence of Cryptococcus neoformans var grubii in the absence of underlying disease. BMC Infect Dis. 2010. https:\/\/doi.org\/10.1186\/1471-2334-10-199.","journal-title":"BMC Infect Dis."},{"key":"7118_CR75","doi-asserted-by":"publisher","DOI":"10.1099\/jmmcr.0.000099","author":"CR Paula","year":"2015","unstructured":"Paula CR, Domingues-Ferreira M, Soares MCP, et al. Cryptococcus gattii: immunological and microbiological study in a patient with neurocryptococcosis. JMM Case Rep. 2015. https:\/\/doi.org\/10.1099\/jmmcr.0.000099.","journal-title":"JMM Case Rep."},{"key":"7118_CR76","doi-asserted-by":"publisher","DOI":"10.1099\/jmmcr.0.000099","author":"DM de Vasconcelos","year":"2015","unstructured":"de Vasconcelos DM, Domingues-Ferreira M, Soares MCP, et al. Cryptococcus gattii: immunological and microbiological study in a patient with neurocryptococcosis. JMM Case Rep. 2015. https:\/\/doi.org\/10.1099\/jmmcr.0.000099.","journal-title":"JMM Case Rep"},{"key":"7118_CR77","doi-asserted-by":"publisher","unstructured":"Amaral do DM, Rocha de RCC, Carneiro LEP, Vasconcelos DM, Abreu de MAMM. Disseminated cryptococcosis manifested as a single tumor in an immunocompetent patient, similar to the cutaneous primary forms. Anais Brasileiros de Dermatologia. 2016;91(5 suppl 1):29\u201331. https:\/\/doi.org\/10.1590\/abd1806-4841.20164582","DOI":"10.1590\/abd1806-4841.20164582"},{"issue":"12","key":"7118_CR78","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1111\/myc.13174","volume":"63","author":"PH Grizante Bari\u00e3o","year":"2020","unstructured":"Grizante Bari\u00e3o PH, Tonani L, Cocio TA, Martinez R, Nascimento \u00c9, von Zeska Kress MR. Molecular typing, in vitro susceptibility and virulence of Cryptococcus neoformans\/Cryptococcus gattii species complex clinical isolates from south-eastern Brazil. Mycoses. 2020;63(12):1341\u201351. https:\/\/doi.org\/10.1111\/myc.13174.","journal-title":"Mycoses"},{"key":"7118_CR79","doi-asserted-by":"publisher","first-page":"e0169","DOI":"10.1590\/0037-8682-0169-2021","volume":"54","author":"E Nascimento","year":"2021","unstructured":"Nascimento E, Bari\u00e3o PHG, von Kress MRZ, et al. Cryptococcosis by Cryptococcus neoformans\/Cryptococcus gattii species complexes in non-HIV-infected patients in southeastern Brazil. Rev Soc Bras Med Trop. 2021;54:e0169-2021. https:\/\/doi.org\/10.1590\/0037-8682-0169-2021.","journal-title":"Rev Soc Bras Med Trop."},{"issue":"4","key":"7118_CR80","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1099\/jmm.0.000698","volume":"67","author":"PF Herkert","year":"2018","unstructured":"Herkert PF, Meis JF, de Salvador LOG, et al. Molecular characterization and antifungal susceptibility testing of Cryptococcus neoformans sensu stricto from southern Brazil. J Med Microbiol. 2018;67(4):560\u20139. https:\/\/doi.org\/10.1099\/jmm.0.000698.","journal-title":"J Med Microbiol."},{"key":"7118_CR81","doi-asserted-by":"publisher","unstructured":"Andrade-Silva LE, Ferreira-Paim K, Ferreira TB, et al. Genotypic analysis of clinical and environmental Cryptococcus neoformans isolates from Brazil reveals the presence of VNB isolates and a correlation with biological factors. In: Nielsen K, editor. PLoS ONE. 2018;13(3):e0193237. https:\/\/doi.org\/10.1371\/journal.pone.0193237.","DOI":"10.1371\/journal.pone.0193237"},{"issue":"1","key":"7118_CR82","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s11046-018-0304-3","volume":"184","author":"AH Damasceno-Escoura","year":"2019","unstructured":"Damasceno-Escoura AH, de Souza ML, de Oliveira NF, et al. Epidemiological, clinical and outcome aspects of patients with cryptococcosis caused by Cryptococcus gattii from a non-endemic area of Brazil. Mycopathologia. 2019;184(1):65\u201371. https:\/\/doi.org\/10.1007\/s11046-018-0304-3.","journal-title":"Mycopathologia"},{"key":"7118_CR83","doi-asserted-by":"publisher","unstructured":"Tseng HK, Liu CP, Ho MW, et al. Microbiological, Epidemiological, and clinical characteristics and outcomes of patients with cryptococcosis in Taiwan, 1997\u20132010. In: Chaturvedi V, editor. PLoS ONE. 2013;8(4):e61921. https:\/\/doi.org\/10.1371\/journal.pone.0061921.","DOI":"10.1371\/journal.pone.0061921"},{"issue":"1","key":"7118_CR84","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s12877-019-1108-0","volume":"19","author":"WC Tsai","year":"2019","unstructured":"Tsai WC, Lien CY, Lee JJ, et al. The clinical characteristics and therapeutic outcomes of cryptococcal meningitis in elderly patients: a hospital-based study. BMC Geriatr. 2019;19(1):91. https:\/\/doi.org\/10.1186\/s12877-019-1108-0.","journal-title":"BMC Geriatr"},{"issue":"4","key":"7118_CR85","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1053\/jinf.2001.0916","volume":"43","author":"P Pitisuttithum","year":"2001","unstructured":"Pitisuttithum P, Tansuphasawadikul S, Simpson AJH, Howe PA, White NJ. A prospective study of aids-associated cryptococcal meningitis in thailand treated with high-dose amphotericin b. J Infect. 2001;43(4):226\u201333. https:\/\/doi.org\/10.1053\/jinf.2001.0916.","journal-title":"J Infect"},{"issue":"9423","key":"7118_CR86","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1016\/S0140-6736(04)16301-0","volume":"363","author":"AE Brouwer","year":"2004","unstructured":"Brouwer AE, Rajanuwong A, Chierakul W, et al. Combination antifungal therapies for HIV-associated cryptococcal meningitis: a randomised trial. Lancet. 2004;363(9423):1764\u20137. https:\/\/doi.org\/10.1016\/S0140-6736(04)16301-0.","journal-title":"Lancet"},{"key":"7118_CR87","doi-asserted-by":"publisher","unstructured":"Dromer F, Mathoulin-P\u00e9lissier S, Launay O, Lortholary O, the French Cryptococcosis study group. Determinants of disease presentation and outcome during cryptococcosis: the CryptoA\/D Study. In: Perfect JR, editor. PLoS Med. 2007;4(2):e21. https:\/\/doi.org\/10.1371\/journal.pmed.0040021.","DOI":"10.1371\/journal.pmed.0040021"},{"key":"7118_CR88","doi-asserted-by":"publisher","unstructured":"Chagas OJ, Buccheri R, de Souza Melhem CM, et al. Usefulness of yeast cell counting and lack of clinical correlation of the antifungal susceptibility testing results in management of aids-associated cryptococcal meningitis. Curr Fungal Infect Rep. 2020;14(1):1\u20138. https:\/\/doi.org\/10.1007\/s12281-020-00368-5.","DOI":"10.1007\/s12281-020-00368-5"},{"key":"7118_CR89","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e32832605fe","author":"T Bicanic","year":"2009","unstructured":"Bicanic T, Brouwer AE, Meintjes G, et al. Relationship of cerebrospinal fluid pressure, fungal burden and outcome in patients with cryptococcal meningitis undergoing serial lumbar punctures. AIDS. 2009. https:\/\/doi.org\/10.1097\/QAD.0b013e32832605fe.","journal-title":"AIDS."},{"issue":"3","key":"7118_CR90","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1097\/QAD.0b013e328333c005","volume":"24","author":"A Loyse","year":"2010","unstructured":"Loyse A, Wainwright H, Jarvis JN, et al. Histopathology of the arachnoid granulations and brain in HIV-associated cryptococcal meningitis: correlation with cerebrospinal fluid pressure. AIDS. 2010;24(3):405\u201310. https:\/\/doi.org\/10.1097\/QAD.0b013e328333c005.","journal-title":"AIDS"},{"issue":"1","key":"7118_CR91","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1093\/infdis\/jit435","volume":"209","author":"EJ Robertson","year":"2014","unstructured":"Robertson EJ, Najjuka G, Rolfes MA, et al. Cryptococcus neoformans ex vivo capsule size is associated with intracranial pressure and host immune response in hiv-associated cryptococcal meningitis. J Infect Dis. 2014;209(1):74\u201382. https:\/\/doi.org\/10.1093\/infdis\/jit435.","journal-title":"J Infect Dis"},{"key":"7118_CR92","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.fgb.2014.10.004","volume":"78","author":"T Bouklas","year":"2015","unstructured":"Bouklas T, Fries BC. Aging as an emergent factor that contributes to phenotypic variation in Cryptococcus neoformans. Fungal Genet Biol. 2015;78:59\u201364. https:\/\/doi.org\/10.1016\/j.fgb.2014.10.004.","journal-title":"Fungal Genet Biol"},{"issue":"5","key":"7118_CR93","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.jmii.2010.08.011","volume":"44","author":"YC Lee","year":"2011","unstructured":"Lee YC, Wang JT, Sun HY, Chen YC. Comparisons of clinical features and mortality of cryptococcal meningitis between patients with and without human immunodeficiency virus infection. J Microbiol Immunol Infect. 2011;44(5):338\u201345. https:\/\/doi.org\/10.1016\/j.jmii.2010.08.011.","journal-title":"J Microbiol Immunol Infect"},{"key":"7118_CR94","doi-asserted-by":"publisher","unstructured":"Brizendine KD, Baddley JW, Pappas PG. Predictors of mortality and differences in clinical features among patients with cryptococcosis according to immune status. In: Feldmesser M, editor. PLoS ONE. 2013;8(3):e60431. https:\/\/doi.org\/10.1371\/journal.pone.0060431.","DOI":"10.1371\/journal.pone.0060431"},{"issue":"11","key":"7118_CR95","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1093\/cid\/ciu596","volume":"59","author":"MA Rolfes","year":"2014","unstructured":"Rolfes MA, Hullsiek KH, Rhein J, et al. The Effect of therapeutic lumbar punctures on acute mortality from cryptococcal meningitis. Clin Infect Dis. 2014;59(11):1607\u201314. https:\/\/doi.org\/10.1093\/cid\/ciu596.","journal-title":"Clin Infect Dis"},{"issue":"8","key":"7118_CR96","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1111\/j.1365-3156.2007.01874.x","volume":"12","author":"CA Liechty","year":"2007","unstructured":"Liechty CA, Solberg P, Were W, et al. Asymptomatic serum cryptococcal antigenemia and early mortality during antiretroviral therapy in rural Uganda. Trop Med Int Health. 2007;12(8):929\u201335. https:\/\/doi.org\/10.1111\/j.1365-3156.2007.01874.x.","journal-title":"Trop Med Int Health"},{"key":"7118_CR97","doi-asserted-by":"publisher","unstructured":"Govender NP, Patel J, van Wyk M, Chiller TM, Lockhart SR, for the Group for enteric, respiratory and meningeal disease surveillance in South Africa (GERMS-SA). Trends in Antifungal Drug Susceptibility of Cryptococcus neoformans Isolates obtained through population-based surveillance in South Africa in 2002\u20132003 and 2007\u20132008. Antimicrob Agents Chemother. 2011;55(6):2606\u20132611. https:\/\/doi.org\/10.1128\/AAC.00048-11.","DOI":"10.1128\/AAC.00048-11"},{"key":"7118_CR98","doi-asserted-by":"publisher","DOI":"10.5812\/archcid.20246","author":"R Hashemi","year":"2014","unstructured":"Hashemi R, Majidi A, Tabatabaey A, Motamed H. Fatal disseminated Cryptococcus infection in an immunocompetent patient. Arch Clin Infect Dis. 2014. https:\/\/doi.org\/10.5812\/archcid.20246.","journal-title":"Arch Clin Infect Dis."},{"issue":"12","key":"7118_CR99","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1111\/myc.12415","volume":"58","author":"H Badali","year":"2015","unstructured":"Badali H, Alian S, Fakhim H, et al. Cryptococcal meningitis due to Cryptococcus neoformans genotype AFLP1\/VNI in Iran: a review of the literature. Mycoses. 2015;58(12):689\u201393. https:\/\/doi.org\/10.1111\/myc.12415.","journal-title":"Mycoses"},{"issue":"suppl_2","key":"7118_CR100","doi-asserted-by":"publisher","first-page":"S152","DOI":"10.1093\/cid\/cix1143","volume":"66","author":"N Ford","year":"2018","unstructured":"Ford N, Shubber Z, Jarvis JN, et al. CD4 cell count threshold for cryptococcal antigen screening of HIV-infected individuals: a systematic review and meta-analysis. Clin Infect Dis. 2018;66(suppl_2):S152\u20139. https:\/\/doi.org\/10.1093\/cid\/cix1143.","journal-title":"Clin Infect Dis"},{"key":"7118_CR101","doi-asserted-by":"publisher","DOI":"10.1111\/myc.12847","author":"A Vena","year":"2018","unstructured":"Vena A, Mu\u00f1oz P, Guinea J, et al. Fluconazole resistance is not a predictor of poor outcome in patients with cryptococcosis. Mycoses. 2018. https:\/\/doi.org\/10.1111\/myc.12847.","journal-title":"Mycoses."},{"key":"7118_CR102","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa1544","author":"L O\u2019Connor","year":"2020","unstructured":"O\u2019Connor L, Van Anh D, Chau TTH, et al. Antifungal susceptibility does not correlate with fungal clearance or survival in aids-associated cryptococcal meningitis. Clin Infect Dis. 2020. https:\/\/doi.org\/10.1093\/cid\/ciaa1544.","journal-title":"Clin Infect Dis"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-022-07118-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-022-07118-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-022-07118-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,9]],"date-time":"2022-02-09T10:02:49Z","timestamp":1644400969000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-022-07118-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,9]]},"references-count":102,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["7118"],"URL":"https:\/\/doi.org\/10.1186\/s12879-022-07118-7","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,9]]},"assertion":[{"value":"22 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This research was developed by the search for the clinical data from retrospective cases of cryptococcosis consequently, the consent to participate was not required of this study. The need of informed consent was waived by the ethical committee from Em\u00edlio Ribas Institute of Infectious Diseases. Besides, a declaration of confidentiality and use of information was required and signed by the authors, before submitting the research to the committees. All methods were performed in accordance with the relevant guidelines and regulations. This study was approved by Research Ethics Committees of the School of Public Health of the University of S\u00e3o Paulo (Certificate of Presentation for Ethical Appreciation: 54949716.8.0000.5421), Adolfo Lutz Institute (Certificate of Presentation for Ethical Appreciation: 54949716.8.3001.0059) and of Em\u00edlio Ribas Institute of Infectious Diseases (Certificate of Presentation for Ethical Appreciation: 54949716.8.2001.0061).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors report no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"138"}}